IBDEI1KC ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25346,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Unspec
 ;;^UTILITY(U,$J,358.3,25346,1,4,0)
 ;;=4^F31.60
 ;;^UTILITY(U,$J,358.3,25346,2)
 ;;=^5003505
 ;;^UTILITY(U,$J,358.3,25347,0)
 ;;=F31.61^^92^1149^5
 ;;^UTILITY(U,$J,358.3,25347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25347,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Mild
 ;;^UTILITY(U,$J,358.3,25347,1,4,0)
 ;;=4^F31.61
 ;;^UTILITY(U,$J,358.3,25347,2)
 ;;=^5003506
 ;;^UTILITY(U,$J,358.3,25348,0)
 ;;=F31.62^^92^1149^6
 ;;^UTILITY(U,$J,358.3,25348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25348,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Moderate
 ;;^UTILITY(U,$J,358.3,25348,1,4,0)
 ;;=4^F31.62
 ;;^UTILITY(U,$J,358.3,25348,2)
 ;;=^5003507
 ;;^UTILITY(U,$J,358.3,25349,0)
 ;;=F31.63^^92^1149^7
 ;;^UTILITY(U,$J,358.3,25349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25349,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Severe w/o Psychotic Feat
 ;;^UTILITY(U,$J,358.3,25349,1,4,0)
 ;;=4^F31.63
 ;;^UTILITY(U,$J,358.3,25349,2)
 ;;=^5003508
 ;;^UTILITY(U,$J,358.3,25350,0)
 ;;=F31.64^^92^1149^8
 ;;^UTILITY(U,$J,358.3,25350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25350,1,3,0)
 ;;=3^Bipolar D/O,Current Episode Mixed,Severe w/ Psychotic Feat
 ;;^UTILITY(U,$J,358.3,25350,1,4,0)
 ;;=4^F31.64
 ;;^UTILITY(U,$J,358.3,25350,2)
 ;;=^5003509
 ;;^UTILITY(U,$J,358.3,25351,0)
 ;;=A81.00^^92^1150^8
 ;;^UTILITY(U,$J,358.3,25351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25351,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25351,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,25351,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,25352,0)
 ;;=A81.09^^92^1150^7
 ;;^UTILITY(U,$J,358.3,25352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25352,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,25352,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,25352,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,25353,0)
 ;;=A81.2^^92^1150^29
 ;;^UTILITY(U,$J,358.3,25353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25353,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,25353,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,25353,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,25354,0)
 ;;=F01.51^^92^1150^32
 ;;^UTILITY(U,$J,358.3,25354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25354,1,3,0)
 ;;=3^Vascular Dementia w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25354,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,25354,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,25355,0)
 ;;=G30.9^^92^1150^4
 ;;^UTILITY(U,$J,358.3,25355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25355,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25355,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,25355,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,25356,0)
 ;;=G31.01^^92^1150^27
 ;;^UTILITY(U,$J,358.3,25356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25356,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,25356,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,25356,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,25357,0)
 ;;=G94.^^92^1150^6
 ;;^UTILITY(U,$J,358.3,25357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25357,1,3,0)
 ;;=3^Brain D/O in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,25357,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,25357,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,25358,0)
 ;;=G31.83^^92^1150^17
